Cost-Effectiveness of Ibrutinib in Adult Patients with Relapsed Chronic Lymphocytic Leukaemia in the Netherlands
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2234
https://www.valueinhealthjournal.com/article/S1098-3015(16)33600-2/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2122
First Page :
A737
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33600-2&doi=10.1016/j.jval.2016.09.2234